Clinical chemistryHumansPregnancyFemaleBiomarkersHypertension
Considerations for Implementation of Serum Biomarker Testing for Suspected Hypertensive Disorders of Pregnancy.
Ashten B Waks, Christina Frasik, Megan C Oakes
Published: 202510.1093/clinchem/hvaf115
Abstract
BACKGROUND: Hypertensive disorders of pregnancy (HDPs) complicate 8% to 9% of all pregnancies. They are a leading cause of maternal and neonatal morbidity and mortality and contribute to over $2.2 billion of health care expenditures annually. In 2023…
Preview only. Read the full abstract at the source